# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038029
Filing Date
2023-08-03
Accepted
2023-08-03 16:19:48
Documents
80
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dvax-20230630.htm iXBRL | 10-Q | 4260946
2 | EX-10.1 | dvax-ex10_1.htm | EX-10.1 | 61870
3 | EX-10.2 | dvax-ex10_2.htm | EX-10.2 | 88489
4 | EX-10.3 | dvax-ex10_3.htm | EX-10.3 | 156042
5 | EX-31.1 | dvax-ex31_1.htm | EX-31.1 | 17801
6 | EX-31.2 | dvax-ex31_2.htm | EX-31.2 | 17443
7 | EX-32.1 | dvax-ex32_1.htm | EX-32.1 | 11493
8 | EX-32.2 | dvax-ex32_2.htm | EX-32.2 | 11922
| Complete submission text file | 0000950170-23-038029.txt |  | 15092336

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | dvax-20230630_cal.xml | EX-101.CAL | 69076
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dvax-20230630.xsd | EX-101.SCH | 76281
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dvax-20230630_pre.xml | EX-101.PRE | 454204
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | dvax-20230630_def.xml | EX-101.DEF | 303270
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dvax-20230630_lab.xml | EX-101.LAB | 599978
74 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-20230630_htm.xml | XML | 3275944

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 231140357
SIC: 2834 Pharmaceutical Preparations